Background/Objectives: Ferrous fumarate is recommended for the fortification of complementary foods based on similar iron absorption to ferrous sulfate in adults. Two recent studies in young children have reported that it is only 30% as well absorbed as ferrous sulfate. The objective of this study was to compare iron absorption from ferrous fumarate and ferrous sulfate in infants, young children and mothers. Subjects/Methods: Non-anemic Mexican infants (6-24 months), young children (2-5 years) and adult women were randomly assigned to receive either 4 mg Fe (women) or 2.5 mg Fe (infants and young children) as either [
Introduction
Iron fortification of foods is a strategy to prevent iron deficiency in infants and young children, however, there has been some uncertainty concerning the bioavailability of some iron fortification compounds (Fomon, 1987; Fuchs et al., 1993; PAHO, FNP, USAID, 2002) . The World Health Organization recommends using ferrous sulfate as the first choice iron fortificant followed by ferrous fumarate and then double the level of electrolytic iron or ferric pyrophosphate (World Health Organization, 2006) . The relative bioavailability (RBV) of an iron compound is the absorption of that compound relative to ferrous sulfate, and RBV has been used to rank iron fortification compounds and to adjust fortification levels. Electrolytic iron, for example, is estimated to be about half as well absorbed as ferrous sulfate and to have an RBV of 50. To provide an equivalent amount of absorbable iron from electrolytic iron as from ferrous sulfate, it is recommended that electrolytic iron be added at double the iron concentration of ferrous sulfate (World Health Organization, 2006) .
As ferrous sulfate causes unacceptable sensory changes in many cereal-based foods (Hurrell, 1997) , most commercial complementary foods are fortified with either ferrous fumarate, ferric pyrophosphate or electrolytic iron. The recommendation to use ferrous fumarate in complementary foods for infants and for feeding a young child was based on iron absorption studies carried out in adults consuming infant cereals. These studies showed that iron absorption from ferrous fumarate, a poorly water-soluble iron compound that is also soluble in dilute acid, was equivalent to that from ferrous sulfate (Hurrell et al., 1989 Fidler et al., 2003) . However, recent studies in Bangladesh with infants consuming a wheat-soy infant cereal, and in Mexico with young children consuming a maltrodextrin/milk-based complementary food, reported that iron absorption from ferrous fumarate was only 25-35% that from ferrous sulfate (Sarker et al., 2004; Perez-Exposito et al., 2005) and that the RBV of ferrous fumarate in young children may thus be only around 30.
The recommendation to use ferrous fumarate for complementary food fortification has thus been cast in doubt, although the reasons for the differences in the RBV of ferrous fumarate in studies with adults, infants and young children are uncertain. One possibility is that iron status of the subjects could influence RBV (Moretti et al., 2006) . In the adult studies, subjects were mainly iron replete, whereas all of the Bangladeshi children were iron-deficient anemic (Sarker et al., 2004) and some of the Mexican children were iron deficient (Perez-Exposito et al., 2005) .
The aim of the present study was to further evaluate the usefulness of ferrous fumarate for complementary food fortification and to compare the absorption of ferrous fumarate relative to ferrous sulfate in infants, young children and adult women. The study focuses on the use of iron fortified complementary foods for the prevention of iron deficiency (that is fed to iron replete children), accepting that is some developing country situations complementary foods can also be useful to treat iron deficiency (that is fed to iron deficient children). Stable isotopes were used to compare iron absorption in nonanemic infants, young children and adult women, from a sweetened maize-milk drink fortified with either ferrous fumarate or ferrous sulfate.
Subjects and methods

Study subjects
The women were recruited from a factory in the urban community of Cuernavaca, 89 km south of Mexico City. Hemoglobin concentration in all women in the factory was determined from finger-prick blood samples, followed by a venous blood sample to determine serum ferritin among non-anemic women. A total of 20 non-anemic women with low iron stores were recruited based on hemoglobin concentration X125 g/l and serum ferritin concentration o25 mg/l. Exclusion criteria included pregnancy and lactation, gastrointestinal or metabolic disorders (inflammatory bowel disease, chronic diarrhea, cystic fibrosis), other chronic illnesses and those taking iron supplements. In all, 20 apparently healthy infants (aged 6-24 months) and 20 apparently healthy children (aged 2-5 years) were recruited from mothers with adequate hemoglobin levels. The subjects and the children's parents were fully informed about the study aims and procedures, and written consent was obtained. The Ethical Committee at the Instituto Nacional de Salud Pú blica, Cuernavaca, Mexico and the Swiss Federal Institute of Technology, Zürich, Switzerland reviewed and approved the protocol.
Sample size
Sample size calculations were based on interindividual and intraindividual variations in iron absorption as observed in previous studies of iron bioavailability in infants and young children (Davidsson et al., 1994 (Davidsson et al., , 2000 . It was estimated that 20 children would be a minimum sample size to detect a 50% significant difference in log mean iron absorption from an arithmetic mean baseline iron absorption of 7%, with 90% power, a significance level of 0.05 (unpaired t-test) and a type I error rate of 5%. Anticipating a dropout rate of 10%, these estimates indicated that at least 20 subjects in each group would be required to complete the studies.
Study design
Women, infants and children were randomly assigned to receive the test meal either with ferrous sulfate or with ferrous fumarate on consecutive days. The test meal was administered as breakfast after an overnight fast. Acceptability of the test meal was confirmed with each infant and child before enrollment in the study. No food or drink was allowed for 3 h after complete intake of the labeled meal. Infants and children remained under close supervision during and after the test meal intake.
In all, 5 ml of venous blood was drawn into EDTA-treated tubes just before intake of the first test meal and again 14 days later. Blood samples were analyzed for the iron status indicators (hemoglobin and serum ferritin) and iron isotopic composition. Body weight and height were measured at each blood sampling point.
Test meal
The test meal was a sweetened maize-milk drink based on the local Mexican maize flour porridge drink 'atole'. It was made from degermed maize flour (24.7%), whole-milk powder (11.7%), 'piloncillo' (a solid form of unrefined brown sugar; 63.5%) and purified water (200 ml) without any added iron or ascorbic acid. Standardized test meals were prepared especially for the study from locally available foods purchased in bulk, except for the degermed maize flour which was unavailable in Mexico and was obtained from Switzerland (Swiss Mill, Zurich, Switzerland). Degermed maize flour was used to minimize the phytic acid content of the flour, which would otherwise reduce the bioavailability of iron from the test meal . The test meal was cooked in a kitchen facility and transported hot to the feeding center at the factory, where a serving of 220 g per woman and 60 g per infant and child was prepared as a breakfast and was followed by the intake of water. All test meals were identical except for the addition of either 4 mg Fe (women) or 2. by Dr Paul Lohmann GmbH (Emmerthal, Germany) from enriched elemental iron using a downscaled procedure of their equivalent commercial manufacturing process. The same procedure has been used for previous studies (Davidsson et al., 2000 (Davidsson et al., , 2001 (Davidsson et al., , 2002 Fidler et al., 2003; Sarker et al., 2004) . Individual ferrous fumarate doses were preweighed into polyethylene tubes, whereby the exact amount added was determined by tube weight, and were then stored. [
58 Fe]-ferrous sulfate was prepared from isotopically enriched elemental iron (Chemgas, Boulogne, France), which was dissolved in 0.1 mol H 2 SO 4 /l and made up to the appropriate concentration. The solution was kept under argon atmosphere in a polyethylene bottle until needed and weighed into individual doses before feeding.
The isotopic composition of both labels was measured in triplicate by negative thermal ionization mass spectrometry using a magnetic sector field mass spectrometer (MAT262; Finnigan MAT, Bremen, Germany) equipped with a multicollector system of Faraday cups for ion detection. The iron concentration of each label was measured in triplicate by inverse isotopic dilution analysis (Walczyk, 1997) . Ferrous fumarate was dissolved in concentrated nitric acid before isotopic dilution. The iron standard of natural isotopic composition was prepared gravimetrically from an isotopic reference material (IRMM-014; E.U. Institute of Reference Materials and Measurements, Geel, Belgium). Isotopic ratios were measured by negative thermal ionization mass spectrometry (Walczyk, 1997) .
Isotopic composition of blood samples
Enriched whole-blood samples were mineralized by microwave digestion using a mixture of concentrated HNO 3 and H 2 O 2 (30%) as oxidizing agents. Iron was separated from the matrix by anion exchange chromatography and a liquidliquid extraction step into diethyl ether . Chemical blanks were processed throughout the procedure. Isotopic composition of separated iron was measured by negative thermal ionization mass spectrometry.
Iron status
Freshly drawn whole-blood samples were aliquoted for the measurement of hemoglobin concentration using a portable HemoCue photometer (Hemocue Inc., Angelholm, Sweden) and standardized techniques. Corresponding quality control material was analyzed at the beginning of each sampling day (Hemocue Inc., Angelholm, Sweden). An aliquot of whole blood was separated for serum ferritin measurements by automated immunoassay (Immulite One; DPC, Los Angeles, CA, USA) at ETH, Zurich, and the remaining whole blood was frozen for later analysis of isotopic composition.
Calculation of iron absorption
The amounts of 57 Fe and 58 Fe isotopic labels in blood, 14 days after administration, were calculated based on the shift of Fe isotopic ratios and the estimated amount of circulating iron in the body. The calculations were based on the principles of isotopic dilution, taking into account that the iron isotopic labels were not mono-isotopic. Circulating iron was calculated based on blood volume and hemoglobin concentration. Blood volume calculations were based on body weight and height according to Brown et al. (1962) for women and Linderkamp et al. (1977) for children. For calculations of fractional iron absorption, 80% incorporation of the absorbed iron into erythrocytes was assumed for women (Hosein et al., 1967) and 90% for the children (9). The RBV of ferrous fumarate was calculated for each set of data.
Statistical analysis
Fractional iron absorption values are presented as geometric means and s.d. All statistical tests were powered at 80% and performed with 95% confidence interval on the log-transformed data, as iron absorption values are not normally distributed. Student's paired t-test was used to compare the data within each age group. The RBV of ferrous fumarate between age groups was compared using Student's unpaired t-test. Statistical power analysis was performed using commercial software (StatMate 2; GraphPad Software Inc., San Diego, CA, USA). Linear regression was used to evaluate the relationship between iron absorption and iron stores (represented by serum ferritin) and Pearson's correlation was used to examine the relationship between serum ferritin and RBV.
Results
Fractional iron absorption values are given for 18 infants, 20 young children and 18 mothers. One mother vomited 3 h after the intake of the test meal and was excluded from the study. The end point blood sample for one other mother was missing. Two infants were excluded because they did not consume all of the test meal. The baseline characteristics of the infants, young children and women who participated in the study are shown in Table 1 . All subjects were nonanemic. Seven women had iron deficiency defined as serum ferritin o12 mg/l, compared with only one infant and one young child with iron deficiency. Mean serum ferritin was 13 mg/l in women compared with 24 and 37 mg/l in infants and young children, respectively.
Iron absorption values are shown in Table 2 . Within each age group, there was no significant difference in the iron absorption from test meals labeled with ferrous fumarate or with ferrous sulfate. Mean iron absorption in women was 17.5-20.5% compared with B5.9-7.2% in infants and young children. The RBV of ferrous fumarate for infants, young children and women is shown in Figure 1 . The mean RBV was 86 for women, 97 for infants and 106 for young children (Table 2) . No association between serum ferritin and fractional iron absorption was found for either infants or young children, whereas for women, an inverse relationship between serum ferritin concentration and iron absorption was seen, which was statistically non-significant. Serum ferritin concentration was not correlated with RBV in the infants, young children or women.
Discussion
The present study found that iron absorption in Mexican infants, young children and women, from a sweetened maize, milk beverage fortified with ferrous fumarate was as good as with ferrous sulfate. These results thus differ from earlier studies in infants in Bangladesh (Sarker et al., 2004) and Mexico (Perez-Exposito et al., 2005) , which reported that iron absorption from complementary foods fortified with ferrous fumarate was only one-third of that from ferrous sulfate. There are several potential explanations for these differences.
One possible explanation is that the RBV of ferrous fumarate varies with the iron status of the subjects. Iron deficiency has been reported to upregulate absorption of soluble iron compounds, such as ferrous sulfate, more effectively than poorly soluble compounds. Moretti et al. (2006) reported that the RBV of micronized, dispersible ferric pyrophosphate added to extruded rice grains varied from 15 in iron-deficient women to almost 100 in iron-replete women (Moretti et al., 2006) . Like micronized dispersible ferric pyrophosphate, ferrous fumarate is only slowly soluble in dilute acid. The results from the Bangladesh study (Sarker et al., 2004) would be most consistent with this hypothesis, Relative bioavailability of ferrous fumarate M Harrington et al as all the Bangladeshi children were iron-deficient anemic, compared with none in the present study. In the study by Perez-Exposito et al. (2005) , 11% of the Mexican children were anemic and 30% were iron deficient compared with iron deficiency in 39% of women, 6% of infants and 5% of children in the present study. The absolute absorption of iron from the iron fortified test meals in the present study was higher in women than in infants or young children. This can be explained by the lower iron status of the women, which caused an upregulation of iron absorption to maintain iron homeostasis (Gavin et al., 1994) . Additionally, the isotope dose was much lower in women when normalized to weight and usual dietary intake than in infants and young children. Although we could find no relationship between RBV of ferrous fumarate and the iron status of our study subjects, this is not unexpected owing to the narrow range of iron status.
Another possible explanation for the widely different RBV values reported for ferrous fumarate is that ferrous sulfate is more sensitive to food matrix effects than ferrous fumarate, and that ascorbic acid and possibly phytic acid have a greater influence on iron absorption from ferrous sulfate than from ferrous fumarate (Moretti et al., 2006) . In the study by Sarker et al. (2004) , the wheat soy infant cereal contained a 3:1 molar ratio of ascorbic acid to iron, so as to overcome the negative effect of phytic acid on iron absorption. The maltodextrin-milk complementary food fed by Perez-Exposito et al. (2005) was also fortified with ascorbic acid at ca 1:1 molar ratio to iron but contained no phytic acid. By contrast, the test meal in the present study did not contain any additional ascorbic acid and had minimal phytic acid. Therefore, it is possible that in the earlier infant studies, the low RBV of ferrous fumarate can be partially attributed to an increased enhancing effect of ascorbic acid on iron absorption from ferrous sulfate.
A final explanation may be related to differences in gastric acid secretion. Gastric acid is necessary to dissolve poorly water-soluble compounds such as ferrous fumarate before absorption. It is possible that in some populations, nutrient deficiencies or infections may decrease gastric acid secretion and thus limit the entry of poorly soluble iron compounds into the common iron pool, which is necessary before absorption (Sarker et al., 2004) .
The consequences of the present findings are that ferrous fumarate can continue to be recommended for the fortification of complementary foods designed to prevent iron deficiency in infants and young children. Such complementary foods would be most common in industrialized countries. In developing countries where infants have a higher prevalence of iron deficiency and iron-deficiency anemia, ferrous fumarate can continue to be used, however, it may be less efficacious than ferrous sulfate, and higher doses may be needed to achieve an equivalent improvement in iron status. It would seem possible that iron absorption from poorly soluble iron compounds such as ferrous fumarate, ferric pyrophosphate and electrolytic iron is less well upregulated by iron deficiency than iron absorption from soluble iron compounds such as ferrous sulfate and NaFeEDTA. If this is confirmed, then the soluble compounds would be preferred for treating iron deficiency via iron fortified foods.
In conclusion, this study has shown that the absorption of ferrous fumarate is similar to that of ferrous sulfate in nonanemic Mexican infants, young children and women consuming a sweetened maize-milk drink. These results indicate that ferrous fumarate is a useful iron fortification compound for complementary foods designed to be fed to largely iron-replete children, to prevent iron deficiency. Further studies are necessary to determine the usefulness of ferrous fumarate as a fortificant in complementary foods designed to treat iron deficiency.
